TY - JOUR
T1 - Dynamic self-assembled meso-structures formed across a wide concentration range in aqueous solutions of propranolol hydrochloride
AU - Yan, Yixuan
AU - Shen, Yichun
AU - Mahmoudi, Najet
AU - Li, Peixun
AU - Tellam, James
AU - Campbell, Richard A.
AU - Barlow, David J.
AU - Edkins, Katharina
AU - Leach, Andrew G.
AU - Lawrence, M. Jayne
PY - 2025/4
Y1 - 2025/4
N2 - HypothesisNanoscale characterisation of the self-associated species formed by amphiphilic pharmaceuticals in aqueous solution carries relevance across their entire journey from development through to manufacture – relevant, therefore, not only as regards formulation of the drug products as medicines, but also potentially relevant to their bioavailability, activity, and clinical side effects. Such knowledge and understanding, however, can only be fully secured by applying a range of experimental and theoretical methodologies.ExperimentsHerein, we apply a synergistic combination of solubility, surface tension, SANS, NMR and UV spectroscopic studies, together with MD simulation and QM calculations, to investigate the meso-structures of propranolol hydrochloride aggregates in bulk aqueous solutions, at concentrations spanning 2.5 mM to > 200 mM. In addition, we explore the effects of adding NaCl to mimic the ionic strength of physiological fluids, and the differences between racemate and single enantiomer.FindingsThere is a continuum of particle sizes shown to exist across the entire concentration range, with molecules joining and leaving on the nanosecond timescale, and with the distributions of aggregate sizes varying with drug and salt concentration. Given that propranolol is a highly prescribed (WHO essential) medicine, disfavouring aggregators from consideration in high-throughput screening for potential new drug candidates − as many have advocated − should thus be done cautiously.
AB - HypothesisNanoscale characterisation of the self-associated species formed by amphiphilic pharmaceuticals in aqueous solution carries relevance across their entire journey from development through to manufacture – relevant, therefore, not only as regards formulation of the drug products as medicines, but also potentially relevant to their bioavailability, activity, and clinical side effects. Such knowledge and understanding, however, can only be fully secured by applying a range of experimental and theoretical methodologies.ExperimentsHerein, we apply a synergistic combination of solubility, surface tension, SANS, NMR and UV spectroscopic studies, together with MD simulation and QM calculations, to investigate the meso-structures of propranolol hydrochloride aggregates in bulk aqueous solutions, at concentrations spanning 2.5 mM to > 200 mM. In addition, we explore the effects of adding NaCl to mimic the ionic strength of physiological fluids, and the differences between racemate and single enantiomer.FindingsThere is a continuum of particle sizes shown to exist across the entire concentration range, with molecules joining and leaving on the nanosecond timescale, and with the distributions of aggregate sizes varying with drug and salt concentration. Given that propranolol is a highly prescribed (WHO essential) medicine, disfavouring aggregators from consideration in high-throughput screening for potential new drug candidates − as many have advocated − should thus be done cautiously.
KW - Colloidal systems
KW - Small angle neutron scattering
KW - Molecular dynamics
KW - Nuclear magnetic resonance
KW - Quantum mechanics
KW - Drug self-association
KW - Propranolol hydrochloride
U2 - 10.1016/j.jcis.2024.12.131
DO - 10.1016/j.jcis.2024.12.131
M3 - Article
SN - 0021-9797
VL - 683
SP - 1135
EP - 1149
JO - Journal of Colloid and Interface Science
JF - Journal of Colloid and Interface Science
IS - Pt 1
ER -